Purchase Order HHSN269201700664P
Award Date 7/1/17
Potential Completion Date 6/30/18
Potential Value $46K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The NIH Clinical Center awarded a purchase order to Fenwal, Inc. valued at $13,000 on June 20, 2017, for blood technology products and services. Performance was to occur in Bethesda, Maryland, with an ultimate completion date of July 31, 2018. The order was issued on a firm fixed-price basis without set-aside designation. Fenwal, a specialist in blood collection, separation, storage, and transfusion products, supplied blood banking consumables and equipment to support the Clinical Center's...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Fenwal, Inc., a global blood technology company, for $225,517.84. The contract covers the delivery of various blood collection, separation, storage, and transfusion products and services to support the NIH's biomedical research initiatives. These include items such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, and preventative maintenance...
- <p>The NIH Clinical Center awarded a firm fixed-price purchase order to Fenwal, Inc. valued at $75,000 on May 8, 2018, with a completion date of June 8, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. Fenwal supplies blood collection, separation, storage, and transfusion products and related equipment to federal health agencies. The order carries firm fixed-price pricing with no small business designation.</p>
- <p>The NIH Clinical Center awarded a purchase order to Fenwal, Inc. valued at $9,687.24 on April 29, 2019, with completion scheduled for May 1, 2019. No set-aside was used. Place of performance is Lake Zurich, Illinois. The order is for firm fixed-price supply of blood technology products and services, likely blood collection, separation, storage, or transfusion consumables and equipment consistent with Fenwal's core offerings to federal health agencies.</p>
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a purchase order contract to Fenwal, Inc., a global blood technology company, for a service agreement for a blood separator device. The firm-fixed-price contract, valued at $139,326.00, has a period of performance through June 30, 2025. Fenwal, a subsidiary of Fresenius Kabi, has received numerous federal contracts to provide blood collection, separation, storage, and transfusion products and...
- This is a federal contract award to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the National Institutes of Health (NIH) Clinical Center. The contract, valued at $56,760.00, is for the purchase of various medical supplies and equipment related to blood collection, separation, storage, and transfusion. The contract includes items such as blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing...
- The U.S. National Institutes of Health (NIH) awarded a $17,058.37 firm-fixed-price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract, which does not have a set-aside designation, is for the provision of medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items. Fenwal has a long history of providing a...
- <p>The NIH Clinical Center awarded a purchase order to Fenwal, Inc. for $24,967.20 on September 20, 2018, with completion by January 2, 2019. The order procures AMICUS apheresis kits. Performance takes place in Lake Zurich, Illinois. Fenwal is a blood technology manufacturer specializing in collection, separation, storage, and transfusion products and equipment. The contract carries firm fixed-price pricing with no set-aside designation.</p>
- <p>The NIH Clinical Center awarded a purchase order to Fenwal, Inc. for $24,300 on July 21, 2017, with completion by August 21, 2017. No set-aside was used. Performance occurs in Bethesda, Maryland. The order covers blood technology products and services, including blood collection assemblies, blood packs with anticoagulant, washing and diluting solutions, apheresis equipment consumables, and related transfusion medicine supplies critical to the Clinical Center's blood banking operations.</p>
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,813 purchase order to Fenwal, Inc. of Long Grove, Illinois for AMICUS apheresis single and double needle kits. The firm fixed price order is for products to be delivered between November 14 and December 14, 2023 in support of blood collection and separation activities at the Clinical Center. Fenwal will provide the requested medical supply items as the prime contractor. No subcontractors or...